Please provide your email address to receive an email when new articles are posted on . Pfizer announced that the FDA has approved Penbraya, the first and only pentavalent vaccine for coverage against ...

Oct 20 (Reuters) - The U.S. Food and Drug Administration (FDA) has approved Pfizer's (PFE.N), opens new tab vaccine Penbraya, making it the first shot to protect against five groups of a deadly ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: FILE PHOTO: A general view of Centers for Disease Control and Prevention (CDC) headquarters in Atlanta (Reuters) -The ...

The US Food and Drug Administration has approved a meningococcal vaccine against the five most common serogroups causing disease in children and young adults. The new formulation called Penbraya is ...

University of Maryland School of Medicine (UMSOM) researchers helped conduct an important new global health study that found a vaccine that protects against five strains of meningitis prevalent in sub ...

The FDA has approved a new Pfizer meningococcal vaccine whose simpler dosing schedule is expected to make it easier for children and young adults to get fully vaccinated to protect against a rare ...

Dr. Samba O. Sow, Director General of CVD-Mali, has led efforts to eradicate meningococcal disease in the African Meningitis Belt for more than a decade. University of Maryland School of Medicine ...

(Reuters) -The U.S. Centers for Disease Control and Prevention issued an advisory on Thursday alerting healthcare providers about an increase in invasive meningococcal disease and urging them to ...

Researchers helped conduct an important new global health study that found a vaccine that protects against five strains of meningitis prevalent in sub-Saharan Africa is safe and effective for use in ...